Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications
- PMID: 35129581
- PMCID: PMC8822445
- DOI: 10.1001/jama.2022.1190
Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications
Abstract
Importance: It remains unknown whether SARS-CoV-2 infection specifically increases the risk of serious obstetric morbidity.
Objective: To evaluate the association of SARS-CoV-2 infection with serious maternal morbidity or mortality from common obstetric complications.
Design, setting, and participants: Retrospective cohort study of 14 104 pregnant and postpartum patients delivered between March 1, 2020, and December 31, 2020 (with final follow-up to February 11, 2021), at 17 US hospitals participating in the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Gestational Research Assessments of COVID-19 (GRAVID) Study. All patients with SARS-CoV-2 were included and compared with those without a positive SARS-CoV-2 test result who delivered on randomly selected dates over the same period.
Exposures: SARS-CoV-2 infection was based on a positive nucleic acid or antigen test result. Secondary analyses further stratified those with SARS-CoV-2 infection by disease severity.
Main outcomes and measures: The primary outcome was a composite of maternal death or serious morbidity related to hypertensive disorders of pregnancy, postpartum hemorrhage, or infection other than SARS-CoV-2. The main secondary outcome was cesarean birth.
Results: Of the 14 104 included patients (mean age, 29.7 years), 2352 patients had SARS-CoV-2 infection and 11 752 did not have a positive SARS-CoV-2 test result. Compared with those without a positive SARS-CoV-2 test result, SARS-CoV-2 infection was significantly associated with the primary outcome (13.4% vs 9.2%; difference, 4.2% [95% CI, 2.8%-5.6%]; adjusted relative risk [aRR], 1.41 [95% CI, 1.23-1.61]). All 5 maternal deaths were in the SARS-CoV-2 group. SARS-CoV-2 infection was not significantly associated with cesarean birth (34.7% vs 32.4%; aRR, 1.05 [95% CI, 0.99-1.11]). Compared with those without a positive SARS-CoV-2 test result, moderate or higher COVID-19 severity (n = 586) was significantly associated with the primary outcome (26.1% vs 9.2%; difference, 16.9% [95% CI, 13.3%-20.4%]; aRR, 2.06 [95% CI, 1.73-2.46]) and the major secondary outcome of cesarean birth (45.4% vs 32.4%; difference, 12.8% [95% CI, 8.7%-16.8%]; aRR, 1.17 [95% CI, 1.07-1.28]), but mild or asymptomatic infection (n = 1766) was not significantly associated with the primary outcome (9.2% vs 9.2%; difference, 0% [95% CI, -1.4% to 1.4%]; aRR, 1.11 [95% CI, 0.94-1.32]) or cesarean birth (31.2% vs 32.4%; difference, -1.4% [95% CI, -3.6% to 0.8%]; aRR, 1.00 [95% CI, 0.93-1.07]).
Conclusions and relevance: Among pregnant and postpartum individuals at 17 US hospitals, SARS-CoV-2 infection was associated with an increased risk for a composite outcome of maternal mortality or serious morbidity from obstetric complications.
Conflict of interest statement
Figures
Similar articles
-
Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19).Obstet Gynecol. 2021 Apr 1;137(4):571-580. doi: 10.1097/AOG.0000000000004339. Obstet Gynecol. 2021. PMID: 33560778 Free PMC article.
-
Association Between Giving Birth During the Early Coronavirus Disease 2019 (COVID-19) Pandemic and Serious Maternal Morbidity.Obstet Gynecol. 2023 Jan 1;141(1):109-118. doi: 10.1097/AOG.0000000000004982. Epub 2022 Oct 27. Obstet Gynecol. 2023. PMID: 36357949 Free PMC article.
-
The Society for Obstetric Anesthesia and Perinatology Coronavirus Disease 2019 Registry: An Analysis of Outcomes Among Pregnant Women Delivering During the Initial Severe Acute Respiratory Syndrome Coronavirus-2 Outbreak in the United States.Anesth Analg. 2021 Aug 1;133(2):462-473. doi: 10.1213/ANE.0000000000005592. Anesth Analg. 2021. PMID: 33830956
-
Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.Reprod Health. 2022 Jul 19;19(1):164. doi: 10.1186/s12978-022-01469-9. Reprod Health. 2022. PMID: 35854384 Free PMC article.
-
Maternal death related to COVID-19: A systematic review and meta-analysis focused on maternal co-morbidities and clinical characteristics.Int J Gynaecol Obstet. 2021 Aug;154(2):212-219. doi: 10.1002/ijgo.13726. Epub 2021 May 18. Int J Gynaecol Obstet. 2021. PMID: 33930185 Free PMC article. Review.
Cited by
-
Peripartum outcomes and immune responses after SARS-CoV-2 infection in the third trimester of pregnancy.BMC Pregnancy Childbirth. 2024 Jul 24;24(1):498. doi: 10.1186/s12884-024-06707-5. BMC Pregnancy Childbirth. 2024. PMID: 39048938 Free PMC article.
-
Association between acquiring SARS-CoV-2 during pregnancy and post-acute sequelae of SARS-CoV-2 infection: RECOVER electronic health record cohort analysis.EClinicalMedicine. 2024 May 24;73:102654. doi: 10.1016/j.eclinm.2024.102654. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 38828129 Free PMC article.
-
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach.Diseases. 2024 May 6;12(5):95. doi: 10.3390/diseases12050095. Diseases. 2024. PMID: 38785750 Free PMC article. Review.
-
Maternal COVID-19 vaccination status and association with neonatal congenital anomalies.Front Pediatr. 2024 Apr 19;12:1355502. doi: 10.3389/fped.2024.1355502. eCollection 2024. Front Pediatr. 2024. PMID: 38706924 Free PMC article.
-
Lung Protective Ventilation during Pregnancy: An Observational Cohort Study.AJP Rep. 2024 Apr 16;14(2):e111-e119. doi: 10.1055/a-2207-9917. eCollection 2024 Apr. AJP Rep. 2024. PMID: 38646587 Free PMC article.
References
-
- Zambrano LD, Ellington S, Strid P, et al. . Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status: United States, January 22-October 3, 2020. Centers for Disease Control and Prevention. Accessed December 1, 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6944e3.htm - PMC - PubMed
-
- Allotey J, Stallings E, Bonet M, et al. ; PregCOV-19 Living Systematic Review Consortium . Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi:10.1136/bmj.m3320 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- UG1 HD040485/HD/NICHD NIH HHS/United States
- UG1 HD040560/HD/NICHD NIH HHS/United States
- UG1 HD027869/HD/NICHD NIH HHS/United States
- UG1 HD040500/HD/NICHD NIH HHS/United States
- UG1 HD053097/HD/NICHD NIH HHS/United States
- UG1 HD040545/HD/NICHD NIH HHS/United States
- UG1 HD040512/HD/NICHD NIH HHS/United States
- UG1 HD027915/HD/NICHD NIH HHS/United States
- UG1 HD087192/HD/NICHD NIH HHS/United States
- U10 HD036801/HD/NICHD NIH HHS/United States
- UG1 HD040544/HD/NICHD NIH HHS/United States
- UG1 HD034208/HD/NICHD NIH HHS/United States
- UL1 TR001873/TR/NCATS NIH HHS/United States
- UG1 HD087230/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous